2nd Advanced Practice Provider Hybrid Symposium
Presented by ibdhorizons
Event Sponsors
We would like to extend a very special thank you to our sponsors for their support of our 6th Annual Pacific Northwest Symposium.
Conference:
- 1 Day – Novel multiplatform in-person & virtual attendance covering the Pacific Northwest region with an estimated 200 attendees.
- In-person attendance will be limited to meet the highest safety standards. A complete virtual conference platform will be offered exclusively if in-person attendance cannot be safely conducted.
- Format will include a series of IBD-focused presentations, panel discussions, and case studies with dynamic attendee participation using audience interactive technology.
Intended Audience
This activity was developed for nurse practitioners, physician assistants, gastroenterology registered nurses, clinical nurse specialists, pharmacists, dietitians, medical assistants, physicians, and family practitioners involved in the care of patients with IBD.
Learning Objectives
At the conclusion of this learning activity, participants will do the following:
- Outline the goals of IBD care and incorporate the latest concepts, including treat-to-target in IBD clinical practice to maximize patient outcomes.
- Appraise the available non-invasive testing (including blood, stool tests, and imaging modalities) to evaluate for disease activity in IBD and interpret these studies relative to other objective markers of disease such as endoscopy.
- Assess current knowledge on infection risk in IBD, including COVID-19, and the implications on managing IBD patients, especially during the current pandemic, including the risk of complications, interrupting therapy, and vaccination guidelines.
- Review the common dermatologic extraintestinal manifestations in IBD (related to disease, therapy, or complications) and apply a practical approach to screen and intervene as needed.
- Review the causes of active symptoms in IBD patients in clinical remission and apply a practical approach to diagnose and manage GI symptoms in the absence of active inflammation.
- Appraise the available telemedicine models of health care delivery with their advantages and limitations and apply this knowledge to enhance equitable IBD patient care access and outcomes, especially for underserved populations.
- Recognize the particular challenges related to fertility, pregnancy, prenatal and postnatal care in IBD and review the latest recommendations.
- Discuss the newly approved and soon-to-be approved biologic and non-biologic therapies for IBD, including the risks, efficacy, and special considerations when utilizing these therapies.
Accreditation and Certification
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Annenberg Center for Health Sciences at Eisenhower and IBDHorizons. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
Physicians
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
The Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
A maximum of 6 contact hours may be earned for successful completion of this activity.
Pharmacists
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-21-105-L01-P. This program is designated for up to 6 contact hours (0.6 CEUs) of continuing pharmacy education credit.
Physician Assistants
This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 6 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 10/16/2021 to 10/16/2021. AAPA reference number: CME-203725.
The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage practitioners to use their own judgement in treating and addressing the needs of each individual patient, taking into account that patient’s unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.
Disclosure Statement
It is the policy of the Annenberg Center for Health Sciences to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty and planners participating in accredited educational activities are expected to identify and reference off-label product use and disclose any relationship with those supporting the activity or any others with products or services available within the scope of the topic being discussed in the educational presentation.
The Annenberg Center for Health Sciences assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE/CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CE/CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
In accordance with the Accreditation Council for Continuing Medical Education Standards, parallel documents from other accrediting bodies, and Annenberg Center for Health Sciences policy, the following disclosures have been made:
Disclosure of Conflict of Interest
Faculty
Anita Afzali, MD, MPH
Consultant for AbbVie, BMS/Celgene, Gilead, Janssen, Pfizer, Takeda; and a speaker for AbbVie, Janssen, Pfizer, Takeda
Karlee Ausk, MD
No relevant commercial relationships to disclose
Mitra Barahimi, MD
Advisory board for Janssen
Sarah Chou, MPAS
No relevant commercial relationships to disclose
Jeff Jacobs, MD
No relevant commercial relationships to disclose
Scott D. Lee, MD
Consultant for AbbVie, Arena, BMS, Eli Lilly, Janssen, UCB
David Suskind, MD
Patent royalties from MicrobiomX LLC; and stockholder for Nimal Health LLC
Ghassan Wahbeh, MD
Consultant and Data and Safety Monitoring Board for AbbVie; and receives research support from AbbVie, Janssen, Takeda
IBDHorizons
All staff at IBDHorizons have no relevant commercial relationships to disclose.
Annenberg Center for Health Sciences at Eisenhower
All staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.
Nurse Reviewers
Heather Jimenez, FNP-C, has nothing to disclose.
Amber Lea Lambert, MSN, FNP-C, DNP, has nothing to disclose.
This activity is supported by educational grants from Ferring Pharmaceuticals Inc.; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Pfizer Inc.; and Takeda Pharmaceuticals USA, Inc.
IBDHorizons Privacy Policy
https:/ibdhorizons.org/privacy-policy
Annenberg Center for Health Sciences Privacy Policy
Annenberg Center for Health Sciences Privacy Policy: Annenberg Center for Health Sciences respects your privacy. We don’t share information you give us or have the need to share this information in the normal course of providing the services and information you may request. If there should be a need or request to share this information, we will do so only with your explicit permission. See Privacy Statement and other information at https://annenberg.net/pages/privacyPolicy.php